Research ExplorerPublicationsDetection and HER2 expression of circulating tumor cells: pr...

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

Standard

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. / Riethdorf, Sabine; Müller, Volkmar; Zhang, Liling; Rau, Thomas; Loibl, Sibylle; Komor, Martina; Roller, Marc; Huober, Jens; Fehm, Tanja; Schrader, Iris; Hilfrich, Jörn; Holms, Frank; Tesch, Hans; Eidtmann, Holger; Untch, Michael; von Minckwitz, Gunter; Pantel, Klaus.

In: CLIN CANCER RES, Vol. 16, No. 9, 9, 2010, p. 2634-2645.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Riethdorf, S, Müller, V, Zhang, L, Rau, T, Loibl, S, Komor, M, Roller, M, Huober, J, Fehm, T, Schrader, I, Hilfrich, J, Holms, F, Tesch, H, Eidtmann, H, Untch, M, von Minckwitz, G & Pantel, K 2010, 'Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.', CLIN CANCER RES, vol. 16, no. 9, 9, pp. 2634-2645. <http://www.ncbi.nlm.nih.gov/pubmed/20406831?dopt=Citation>

APA

Riethdorf, S., Müller, V., Zhang, L., Rau, T., Loibl, S., Komor, M., Roller, M., Huober, J., Fehm, T., Schrader, I., Hilfrich, J., Holms, F., Tesch, H., Eidtmann, H., Untch, M., von Minckwitz, G., & Pantel, K. (2010). Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. CLIN CANCER RES, 16(9), 2634-2645. [9]. http://www.ncbi.nlm.nih.gov/pubmed/20406831?dopt=Citation

Vancouver

Riethdorf S, Müller V, Zhang L, Rau T, Loibl S, Komor M et al. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. CLIN CANCER RES. 2010;16(9):2634-2645. 9.

Bibtex

@article{a19dc6e1661548d8a5fe103e9e3ab7ea,
title = "Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.",
abstract = "This study was aimed at detecting and characterizing circulating tumor cells (CTC) before and after neoadjuvant therapy (NT) in the peripheral blood of patients with breast cancer.",
author = "Sabine Riethdorf and Volkmar M{\"u}ller and Liling Zhang and Thomas Rau and Sibylle Loibl and Martina Komor and Marc Roller and Jens Huober and Tanja Fehm and Iris Schrader and J{\"o}rn Hilfrich and Frank Holms and Hans Tesch and Holger Eidtmann and Michael Untch and {von Minckwitz}, Gunter and Klaus Pantel",
year = "2010",
language = "Deutsch",
volume = "16",
pages = "2634--2645",
journal = "CLIN CANCER RES",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

RIS

TY - JOUR

T1 - Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

AU - Riethdorf, Sabine

AU - Müller, Volkmar

AU - Zhang, Liling

AU - Rau, Thomas

AU - Loibl, Sibylle

AU - Komor, Martina

AU - Roller, Marc

AU - Huober, Jens

AU - Fehm, Tanja

AU - Schrader, Iris

AU - Hilfrich, Jörn

AU - Holms, Frank

AU - Tesch, Hans

AU - Eidtmann, Holger

AU - Untch, Michael

AU - von Minckwitz, Gunter

AU - Pantel, Klaus

PY - 2010

Y1 - 2010

N2 - This study was aimed at detecting and characterizing circulating tumor cells (CTC) before and after neoadjuvant therapy (NT) in the peripheral blood of patients with breast cancer.

AB - This study was aimed at detecting and characterizing circulating tumor cells (CTC) before and after neoadjuvant therapy (NT) in the peripheral blood of patients with breast cancer.

M3 - SCORING: Zeitschriftenaufsatz

VL - 16

SP - 2634

EP - 2645

JO - CLIN CANCER RES

JF - CLIN CANCER RES

SN - 1078-0432

IS - 9

M1 - 9

ER -